DE1073150B - - Google Patents
Info
- Publication number
- DE1073150B DE1073150B DENDAT1073150D DE1073150DA DE1073150B DE 1073150 B DE1073150 B DE 1073150B DE NDAT1073150 D DENDAT1073150 D DE NDAT1073150D DE 1073150D A DE1073150D A DE 1073150DA DE 1073150 B DE1073150 B DE 1073150B
- Authority
- DE
- Germany
- Prior art keywords
- lipoid
- solution
- ester
- insoluble residue
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 20
- 239000002158 endotoxin Substances 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 239000002244 precipitate Substances 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- -1 lipid esters Chemical class 0.000 claims description 7
- XBDQKXXYIPTUBI-UHFFFAOYSA-M propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 150000003512 tertiary amines Chemical class 0.000 claims description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 4
- 230000002378 acidificating Effects 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N Diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- KSSNXJHPEFVKHY-UHFFFAOYSA-N phenol;hydrate Chemical compound O.OC1=CC=CC=C1 KSSNXJHPEFVKHY-UHFFFAOYSA-N 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims 1
- 230000003301 hydrolyzing Effects 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000588921 Enterobacteriaceae Species 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 150000004676 glycans Polymers 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Polymers 0.000 description 4
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 230000001580 bacterial Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000009910 diseases by infectious agent Diseases 0.000 description 3
- 150000008273 hexosamines Chemical class 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000003911 Arachis Nutrition 0.000 description 1
- 240000005781 Arachis hypogaea Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100020197 CFP Human genes 0.000 description 1
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010005642 Properdin Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 102000004965 antibodies Human genes 0.000 description 1
- 108090001123 antibodies Proteins 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002346 endotoxic Effects 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
DE1073150B true DE1073150B (sv) | 1960-01-14 |
Family
ID=597468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT1073150D Pending DE1073150B (sv) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1073150B (sv) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3048699A1 (de) * | 1980-12-23 | 1982-07-08 | Chisato Tokyo Maruyama | "immuntherapeutisches mittel, geeignet gegen turmoren, enthaltend ein lipopolysaccharid als einen aktiven bestandteil" |
-
0
- DE DENDAT1073150D patent/DE1073150B/de active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3048699A1 (de) * | 1980-12-23 | 1982-07-08 | Chisato Tokyo Maruyama | "immuntherapeutisches mittel, geeignet gegen turmoren, enthaltend ein lipopolysaccharid als einen aktiven bestandteil" |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2219635A1 (de) | Insulinprodukt | |
EP0220453B1 (de) | Verwendung von Pflanzenpollenextrakten zur Herstellung von das Wachstum von Tumorzellen hemmenden pharmazeutischen Präparaten und Verfahren zu ihrer Herstellung | |
DE2947646C2 (de) | Substanz mit Interferon induzierender Aktivität, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE1073150B (sv) | ||
DE2234832C2 (de) | Proteinfreies Hormonkonzentrat von Säugetier-Nebenschilddrüsen, dessen Herstellung und dieses Hormonkonzentrat enthaltende pharmazeutische Präparate | |
DE2943167C2 (sv) | ||
AT212491B (de) | Verfahren zur Herstellung eines gereinigten Lipoids | |
DE1076888B (de) | Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke | |
DE3004018C2 (sv) | ||
DE932150C (de) | Verfahren zur Herstellung therapeutischer Reizstoffe | |
DE3249514T1 (de) | Arzneimittel mit antikarzinogener Wirkung | |
AT200257B (sv) | ||
DE2146395C3 (de) | N-p-Toluolsulfonyl-5-methyl- d2 -pyrazolin-1karbonamid und Verfahren zu seiner Herstellung | |
DE1175389B (de) | Verfahren zur Herstellung stabiler, waessriger Lipoid-Dispersionen | |
DE1617403C (de) | Verfahren zur Gewinnung einer weiteren antibiotisch wirksamen Xerosinfraktion | |
DE3215482C2 (de) | Komplexe aus Natriumsalzen von 4-Hydroxy-cumarinen und Alkoholen und Verfahren zu deren Herstellung | |
DE941640C (de) | Verfahren zur Herstellung von Saeure-Additionssalzen des Erythromycins oder Carbomycins | |
DE1959603A1 (de) | Kristalline Kombination aus L-Asparaginase und einem Metall- oder Metalloidion und Verfahren zu ihrer Herstellung | |
DE933450C (de) | Verfahren zur Herstellung eines neuen Salzes von Penicillin G | |
DE972336C (de) | Verfahren zur Gewinnung von stabilen, besonders fuer die Oraltherapie geeigneten Penicillinen | |
AT224807B (de) | Verfahren zur Gewinnung eines neuen tumorhemmenden Polysaccharids | |
DE711720C (de) | Verfahren zur Anreicherung und Gewinnung eines die Steigerung der Leukocytenbildung bewirkenden Stoffes | |
DE1518141C3 (de) | Verfahren zur Herstellung eines Kon densationsproduktes aus einem Rohextrakt aus Podophyllum Rhizomen mit Benzaldehyd | |
DE601995C (de) | Verfahren zur Darstellung von komplexen Antimonverbindungen | |
DE654960C (de) | Verfahren zur Darstellung von wasserstoffuebertragenden Co-Enzymen |